Press / media

As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.

Latest press releases

3.3.2021

Periodontitis: Researchers search for a new active substance

Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous. It was developed and tested for the first time by a team from Martin Luther University Halle-Wittenberg (MLU), the Fraunhofer Institute for Cell Therapy and Immunology IZI and Periotrap Pharmaceuticals GmbH, a Fraunhofer IZI spin-off. The aim is to neutralise only bacteria that cause periodontitis while sparing harmless bacteria. The study appeared in the "Journal of Biological Chemistry".
Read more

4.2.2021

SaxoCell – “living drug” Made in Saxony

Saxony-based consortium comes out on top in the BMBF Clusters4Future initiative. In a digital press conference held by the German Federal Ministry of Education and Research (BMBF) on February 3, 2021, the SaxoCell research consortium was announced as one of the clusters selected for funding. The consortium comprises experts from the TU Dresden, Leipzig University, Chemnitz Hospital and the Fraunhofer Institute for Cell Therapy and Immunology. Over the next three years, the project partners will collaborate with partners from academia and industry to provide novel cell and gene therapies for previously incurable diseases.
Read more

1.2.2021

Optimization of novel immune cell therapies

Fraunhofer Institute for Cell Therapy and Immunology IZI and Klinikum Chemnitz gGmbH (Chemnitz hospital) expand cooperation
Read more

19.11.2020

Rapid diagnostic device for trachoma eye infection delivers first promising result

A molecular biological, chip-based rapid test for the diagnosis of the eye infection trachoma developed at the Fraunhofer Institute for Cell Therapy and Immunology IZI has proven promising in first studies. The results of the study carried out together with the London School of Hygiene & Tropical Medicine and the Kilimanjaro Christian Medical Centre, Tanzania, have now been published in the journal "Parasites & Vectors". The development of the DjinniChip was supported by the ClearTrachoma project of the non-profit organization Task Force for Global Health in a program of the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD).
Read more

Archive press releases

RSS Newsfeed

Get the latest news about the Fraunhofer IZI. Through our RSS-feed you have the opportunity to follow all our press releases and receive them right when they are published.

Social media

 

Media library

 

Publications

 

Events